1. Home
  2. MDXH vs JVSA Comparison

MDXH vs JVSA Comparison

Compare MDXH & JVSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXH
  • JVSA
  • Stock Information
  • Founded
  • MDXH 2003
  • JVSA 2021
  • Country
  • MDXH Belgium
  • JVSA Hong Kong
  • Employees
  • MDXH N/A
  • JVSA N/A
  • Industry
  • MDXH
  • JVSA
  • Sector
  • MDXH
  • JVSA
  • Exchange
  • MDXH Nasdaq
  • JVSA NYSE
  • Market Cap
  • MDXH 84.6M
  • JVSA 82.7M
  • IPO Year
  • MDXH 2021
  • JVSA 2024
  • Fundamental
  • Price
  • MDXH $2.00
  • JVSA $10.86
  • Analyst Decision
  • MDXH Buy
  • JVSA
  • Analyst Count
  • MDXH 1
  • JVSA 0
  • Target Price
  • MDXH $6.00
  • JVSA N/A
  • AVG Volume (30 Days)
  • MDXH 73.0K
  • JVSA 73.5K
  • Earning Date
  • MDXH 05-14-2025
  • JVSA 01-01-0001
  • Dividend Yield
  • MDXH N/A
  • JVSA N/A
  • EPS Growth
  • MDXH N/A
  • JVSA 719.53
  • EPS
  • MDXH N/A
  • JVSA 0.27
  • Revenue
  • MDXH $94,507,000.00
  • JVSA N/A
  • Revenue This Year
  • MDXH $23.50
  • JVSA N/A
  • Revenue Next Year
  • MDXH $17.30
  • JVSA N/A
  • P/E Ratio
  • MDXH N/A
  • JVSA $39.98
  • Revenue Growth
  • MDXH 25.46
  • JVSA N/A
  • 52 Week Low
  • MDXH $1.35
  • JVSA $10.13
  • 52 Week High
  • MDXH $3.50
  • JVSA $11.91
  • Technical
  • Relative Strength Index (RSI)
  • MDXH 48.51
  • JVSA N/A
  • Support Level
  • MDXH $2.07
  • JVSA N/A
  • Resistance Level
  • MDXH $2.21
  • JVSA N/A
  • Average True Range (ATR)
  • MDXH 0.12
  • JVSA 0.00
  • MACD
  • MDXH -0.02
  • JVSA 0.00
  • Stochastic Oscillator
  • MDXH 11.76
  • JVSA 0.00

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

About JVSA JVSPAC ACQUISITION CORP

JVSPAC Acquisition Corp is blank check company.

Share on Social Networks: